Press-release for stocks in the professional, scientific, and technical services sector

Prices are updated after-hours

Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 15:20) - biospace.com/
CMPX | $1.49 -2.61% -2.0% 170K

| -60.65% | O: 4.76% H: 1.32% C: -5.02%
biopharma global conference therapeutics

| -19.9% | O: 3.27% H: 0.98% C: -5.61%
preclinical medical therapeutics

Ehave Provides Progress Update on its HPPD Study with University of Melbourne
Published: 2023-02-02 (Crawled : 15:00) - globenewswire.com
EHVVF | $0.001 155.0% 0

| -80.0% | O: -26.0% H: 45.95% C: 45.95%
update study

Definitive Healthcare greatly expands all-payor medical and prescription claims coverage
Published: 2023-02-02 (Crawled : 15:00) - globenewswire.com
DH | $7.04 -2.09% -2.28% 410K

| -43.81% | O: 3.46% H: 4.23% C: 2.15%
medical

Definitive Healthcare introduces the Atlas Dataset
Published: 2023-02-02 (Crawled : 15:00) - globenewswire.com
DH | $7.04 -2.09% -2.28% 410K

| -43.81% | O: 3.46% H: 4.23% C: 2.15%

Unicycive Announces Exclusive License and Development Agreement with Lotus for Renazorb in the Republic of Korea
Published: 2023-02-02 (Crawled : 14:00) - globenewswire.com
UNCY | $1.09 -5.63% -5.96% 890K

| 98.65% | O: 0.24% H: 5.16% C: -7.27%
license agreement renazorb

Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
XLO | $1.28 4.06% 0.0% 130K

| -65.41% | O: 0.0% H: 7.84% C: 0.81%
day therapeutics

Singular Genomics Joins the 10x Genomics Compatible Partner Program
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
OMIC | $0.3889 -2.16% -2.63% 24K

| -84.73% | O: -0.38% H: 11.11% C: 9.58%
genomics program

Reneo Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 13:00) - globenewswire.com
RPHM | $1.76 -0.57% -0.57% 76K

| -33.21% | O: 0.38% H: 4.88% C: -0.38%
biopharma pharmaceuticals global conference

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
Published: 2023-02-02 (Crawled : 03:00) - globenewswire.com
VERA | $39.48 -1.33% -1.27% 860K